Pet parents and their furry friends enjoyed a fun evening complete with delightful buffet and unique attractions at the fundraising dinner organized by Bow & Wow and CARA Welfare Philippines.
It’s a flavorful adventure with the new Jolly Crispy Flavored Fries!
· Jolly Crispy Fries get a tasty update: introducing the new Super Cheese and Sour Cream flavors!
· Super Cheese is a combination of multiple cheese varieties for an enhanced dimension of flavor
· Sour Cream is perfect for those who crave zing with every bite of golden, crispy potato fries
· Jolly Crispy Flavored Fries are available in Jollibee stores nationwide for P40.00 for regular size, P65.00 for large, and for those who can’t get enough, jumbo size for P80.00
· Beat the heat with summer-ready Jolly Crispy Flavored Fries + Jollibee Float combo, starting at P65.00
Jolly Crispy Flavored Fries are available in and April 25 in Visayas and Mindanao
· “For years, friends have enjoyed memorable bonding moments over their favorite Jolly Crispy Fries. Today, we add flavor to your barkada experience with the new Jolly Crispy Flavored Fries. Coming in two exciting flavors—in zesty Super Cheese and delicious Sour Cream,” said Jollibee Senior Marketing Manager Kay Segismundo. “These new exciting twists to your favorite Jolly Crispy Fries are now available in Luzon and will be available in Visayas and Mindanao by April 25.”
Choose your side!
· Are you #TeamSuperCheese or #TeamSourCream? The Jolly Crispy Flavored Fries teams were led by Loyola Meralco Sparks FC players James and Phil Younghusband, Ricardo Padilla, Curt Dizon, and Simon Greatwich, along with Youtube personalities Wil Dasovich and Janina Vela.
Arla Cheesy Spread, the only cheese spread with actual read cheese is now in the Philippines.
OPPO’s camera phone 16-megapixel front camera has been finally launched in the Philippines.
The process of ageing begins at birth. Through the decades, science has made tremendous progress in extending human life but there is still a pressing need to prolong our active and healthy years.
As a commitment to helping Filipinos live young longer, Nestlé Health Science recently held the Opt to Be Active media roundtable discussion to share their new discoveries and secrets in nutrition and healthy ageing. Nutritionists and fitness coaches were also present in the event to help attendees assess their nutrition and health status.
Dr. Jimmy Bautista, Medical & Scientific Affairs Lead at Nestlé Health Science and Dr. Marianna Sioson, Section of Nutrition Head at The Medical City, shared how Filipinos can achieve a full and active life by making proactive choices such as maintaining a healthy diet, exercising regularly, and keeping the mind active.
In his lecture held at the Manila Diamond Hotel, Dr. Bautista stressed that the human body has two different ages—a chronological age and a biological age.
“People who optimize their health may have a biological age that is 10 years younger than their chronological age,” said Dr. Bautista. “At the same time, the presence of chronic conditions may accelerate the body’s decline, making us biologically older than our chronological age.”
Dr. Sioson, on the other hand, emphasized that it is never too early to assess if we are meeting our energy and nutrient requirements. Since the prevalence of developing malnutrition significantly increases as we grow older, there is a pressing need to start taking nutritionally complete oral supplements to continue to live a young and active lifestyle.
“We want Filipinos to ask themselves if there is a need for them to optimize their health and nutrient intake so that they can achieve a full life,” said Dr. Sioson.
Where nutrition becomes therapy
Filipinos often find themselves caught in a battle between indulging and being healthy and, more often than not, the earlier prevails. This gives rise to lifestyle-related, non-communicable diseases (NCD). In a report by the World Health Organization, NCDs account for 61 percent of total deaths in the country. The organization defines non-communicable diseases as chronic diseases that are not passed from person to person. NCDs are grouped into four main types—cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes.
Simple lifestyle changes like preparing healthy meals and optimizing your nutrient intake can be the body’s best defenses against these diseases.
Nestlé Health Science champions this approach by providing novel ways to bridge the gap between nutrition and therapy. The health science arm of the leading global nutrition, health and wellness company strongly believes that the food we consume on a daily basis is the largest single influence on our health.
“By shifting the way people manage health and nutrition, we have the force to improve lives around the world because beyond medicine, there is nutritional therapy,” said Nestlé Health Science
Country Business Manager Angela Sison. “This is what is considered the point where scientific research meets human insight.”
Formed in 2011, Nestlé Health Science is an innovative and fundamentally different type of health science company that is focused specifically on advancing nutritional therapy to change the course of health.
To know more about Nestlé Health Science, visit www.nestlehealthscience.com.
Famous Chef from the Laguna area and their team are going to take part on their greatest challenge in the kitchen. Kitchen Masters is expected to be a battle of culinary skills and strategies.
The introduction of Chef and Apprentices took place yesterday April 11, 2016 at SM City Sta Rosa. Five Laguna-based chefs face each other in a culinary competition built around specific theme ingredients.
Each team will be given the challenge to prepare and cook three 3 dishes. (appetizer, pasta and salad) highlighting respective ingredients from Laguna —Itik, Kesong Puti and Paco.
Each team will be composed of one featured Chef and 5 apprentices from MCL’s Diploma in Culinary Arts.
Professional Serving Methods 50 points
Taste 40 points
Teamwork 10 points
The teams are:
Chef Karen finished culinary arts and baking at Global City Innovative College. Chef Karen works as a Sous Chef at Buttero, an Italian and Bistro at Taguig City for the last 2 years.
Chef Cherriza CanlasFilamor is currently a Sous Chef at Buttero, an Italian and Bistro at Taguig City for 2 years. Project based Chef Consultant for 3 years at Universal Harvester Inc. in charge of renovation and layouting, finished Culinary Arts and Baking at Global City Innovative College.
Chef Von a Head Chef and Operations Manager of Bonitos Bar and Restaurant. He is also the Head Chef of Amorita Buffet Restaurant and Events Place. He also serves as the Corporate Secretary of the Red Brick House.
Chef Roel is currently an Assistant Professor at Malayan Colleges Laguna. He handles professional subjects on Business Research, Banquet and Catering operations, and Food and Beverage Control System ,among others. He graduated Cum Laude in Bachelor of Science in Hotel and Restaurant Management from the University of Sto. Tomas
Chef Emmanuel Recio is the owner of Le Chef Emamanuel French and Italian Cusine at Sta Cruz Laguna, has a knowledge in baking, Cake decorating, commercial cooking, basic table set-up, waitering and housekeeping. A Graduate of BS Hotel and Restaurant Management at Laguna State Polytechnic University.
Join us, as we witnessing the Kitchen Masters battle culminates on April 17 at SM City Sta Rosa.
BlueWater Day Spa announced the addition of some of the country’s most well-loved actresses to its roster of brand ambassadors as well as the launch of an exciting new service.
I love to swim as this would always be a breather to me. Other than water sports activities, I tried scuba diving lesson and did wind surfing.
Intel Philippines unveiled a series of new devices and technologies that will transform the way technology is consumed in the Philippines and deliver a new technology-enabled experience.
Innovation showcased in the Philippines for the first time include the 6th Generation Intel Core processors that power a broad range of computing form factors, as well as the Intel Curie module which provides real-time sensor data and will enable consumers to experience technology like never before.
Technology adoption within the local community is rising, with over 46% of the population now connected online. At Intel, we are proud to be at the heart of this increasingly connected society as we help create new possibilities and innovations to empower Filipinos in realizing their potential and capabilities through our technology.
Intel’s best processor ever – The rapid growth in technology adoption continues to drive demand for better performing, more efficient devices that help users do more. As the nature of technology shifts to adopt to the needs of consumers Intel’s efforts bring to life even more experiences for its users.
The 6th generation intel core processor, Intel’s best processor ever, deliver enhanced performance and new immersive experiences at the lowest power levels ever. These enhancements include a new quad cor intel Core 15 processor that offers up to 60 percent improved mobile multitasking.
The 6th generation Intel Core processors also enable amazing experiences for the user. Devices can now utilize WiGig and intel WiDi features for wireless display freedom, Intel RealSense Technology and Windows Hello for password-free log-ins, and the integration of intel RealSense and Cortana for more immersive interactions with virtual assistants. More tha ever, these experiences will redefine technology consumption and creation in the years to come.
The spark of hope has never been brighter for Filipino patients with advanced stages of lung cancer and melanoma. MSD in the Philippines, a leader in oncology research and development just introduced immunotherapy, one of the most innovative cancer treatment methods to date.
One type of immunotherapy called immune checkpoint inhibitors is a form of cancer treatment that prevents the interaction between the immune system’s T-cells and the tumors. When tumors and T-cells interact, a protein found in the tumor called the Programmed Death-Ligand 1 (PD-L1) deactivates T-cells so they become incapable of recognizing and destroying cancer cells. Through immunotherapy, this interaction is blocked so that T-cells can detect and ward off the cancer cells.
In the Philippines, the anti PD-L1 immunotherapy drug Pembrolizumab received approval from the Food and Drug Administration (FDA) for the treatment of advanced or metastatic lung cancer and melanoma after failing first-line treatment. In a media roundtable symposium held March 17 in Manila, Dr Gerardo Cornelio, Cancer Institute Head of St. Luke’s Medical Center Global City shared that “Pembrolizumab has the potential to become an integral part of cancer treatment. It has and will be tested across a broad spectrum of cancers.”
Burden of Disease
Cancer is one of the most challenging diseases and annual cases are expected to rise to 22 million within the next two decades. In 2012 alone, there were 14 million new cases reported by the World Health Organization (WHO) with 8.2 million cancer-related deaths. A significant contributor to this statistic is lung cancer, which is the top cause of cancer mortality for both sexes worldwide.
Sadly, incidence from the Philippines is not far off from the global data. According to Globocan 2012, Iung cancer is the second most common cancer in incidence and mortality among Filipino men and women.
As for melanoma, a skin cancer whose risk factors include sun exposure, fair complexion and genetics, around 300 Filipinos are affected annually. Though melanoma is not one of the most common cancers in the country, early diagnosis remains a challenge for most patients.
The good news is that for many cancers there have been significant breakthroughs – from prevention to treatment options – however, the unmet needs remain high.
Durable responses, lower toxicities
Clinical trials have shown immunotherapy’s efficacy in the treatment of advanced lung cancer and melanoma. According to a study published in LANCET, Pembrolizumab showed superior overall survival with less high-grade toxicity for previously treated, PD-L1-positive advanced non-small cell lung cancer. Results of the trials showed that the most common side effects for lung cancer patients receiving Pembrolizumab were decreased appetite, fatigue, nausea, and rash.
Clinical trials also showed that Pembrolizumab has superior anticancer activity in patients with advanced melanoma who failed previous therapies. In terms of safety profile, Pembrolizumab showed a lower incidence of treatment-related adverse events compared to chemotherapy. .
Biomarkers play a key role in patient response
The expression of a certain biomarker in patients’ tumors played an important role in their response to Pembrolizumab. Biomarkers are proteins found in a patient’s tissue, blood or fluids that can help determine the outcome of a patient’s disease or response to medication. Clinical trials have shown that if a patients’ tumors express the biomarker Programmed Death Ligand-1 (PD-L1), patients are more likely to have a better response to the drug.
Hope within reach
“Addressing the rising incidence of cancer is indeed a tough road to embark on. MSD has been dedicating its resources to developing innovative oncology medicines. Pembrolizumab propelled our research efforts to understand of the role of the immune system and the PD-L1 pathway in cancer treatment” said Dr. Beaver Tamesis, President and Managing Director of MSD in the Philippines.
With this immunotherapy finally available in the Philippines, cancer patients need not equate being diagnosed with advanced or metastatic lung cancer or melanomas a death sentence. Thanks to this breakthrough in cancer medication, patients in the Philippines and abroad have a ray of hope and confidence in what used to be a hopeless case.